面向患者中心的创新:变革性肾脏替代设备患者报告结局指标的概念框架
透析依赖的肾衰竭患者功能状态和整体健康显著下降,但肾脏替代治疗(KRT)技术数十年缺乏实质进展。肾脏健康倡议(KHI)工作组提出健康相关生活质量患者报告结局指标(PROM)概念框架,映射并优先排序现有PROM,明确未来需填补的空白以推进变革性KRT设备临床试验。
要点
- 透析依赖患者功能状态和健康相关生活质量显著下降,需重视患者报告结局。
- FDA认可将患者视角纳入产品全生命周期,鼓励在监管临床试验中考虑PRO。
- KHI工作组提出HRQoL PROM概念框架,映射并优先排序现有PROM。
核心结论
- 提出健康相关生活质量PROM概念框架,映射并优先排序现有PROM,识别差距以推进变革性KRT设备临床试验。
研究设计与样本
- 肾脏健康倡议(KHI)工作组(美国肾脏病学会与FDA公私合作)召开会议,制定概念框架、映射并优先排序PROM、描述下一步。
主要发现
- 透析依赖肾衰竭患者经历疾病和治疗相关的功能状态及整体健康显著下降。
- 数十年KRT技术缺乏实质性进展,患者视角整合到KRT产品开发 historically 有限。
- FDA认可将患者视角纳入产品全生命周期,鼓励在适当情况下于监管临床试验中考虑PRO。
关键数值与推荐
- 工作组任务包括:制定HRQoL PROM概念框架;识别并映射现有PROM至框架,基于监管环境使用证据优先排序;描述识别PROM用于变革性KRT设备监管临床试验的下一步。
临床怎么用
- 临床可参考该概念框架关注患者报告的功能状态与整体健康,为未来变革性KRT设备临床试验的PROM选择提供依据。
局限性
- 本文为概念框架与PROM映射总结,未报告具体PROM的心理测量学数据或临床验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Individuals with dialysis-dependent kidney failure experience considerable disease- and treatment-related decline in functional status and overall well-being. Despite these experiences, there have been few substantive technological advances in KRT in decades. As such, new federal initiatives seek to accelerate innovation. Historically, integration of patient perspectives into KRT product development has been limited. However, the US Food and Drug Administration recognizes the importance of incorporating patient perspectives into the total product life cycle (i.e., from product conception to postmarket surveillance) and encourages the consideration of patient-reported outcomes in regulatory-focused clinical trials when appropriate. Recognizing the significance of identifying patient-reported outcome measures (PROMs) that capture contemporary patient priorities, the Kidney Health Initiative, a public-private partnership between the American Society of Nephrology and US Food and Drug Administration, convened a workgroup to (1) develop a conceptual framework for a health-related quality of life PROM; (2) identify and map existing PROMs to the conceptual framework, prioritizing them on the basis of their supporting evidence for use in the regulatory environment; and (3) describe next steps for identifying PROMs for use in regulatory clinical trials of transformative KRT devices. This paper summarizes the proposed health-related quality-of-life PROM conceptual framework, maps and prioritizes PROMs, and identifies gaps and future needs to advance the development of rigorous, meaningful PROMS for use in clinical trials of transformative KRT devices.
引用
- Flythe JE, Hilliard TS, Ikeler K, et al. Toward Patient-Centered Innovation: A Conceptual Framework for Patient-Reported Outcome Measures for Transformative Kidney Replacement Devices. Clin J Am Soc Nephrol. 2020. PMID: 32276947. doi:10.2215/CJN.00110120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。